Submit to Special Issue Submit Abstract to Special Issue Review for Cancers Propose a Special Issue

Journal Menu

Journal Browser

Special Issue "Approaches to Improve the Prognosis of Head-and-Neck Cancer"

Print Special Issue Flyer
Special Issue Editors
Special Issue Information
Keywords
Published Papers

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Survivorship and Quality of Life".

Deadline for manuscript submissions: 31 December 2023 | Viewed by 4539

Share This Special Issue

Special Issue Editors

Dr. Hajime Suzuki

E-Mail Website
Guest Editor

Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
Interests: cancer cachexia; sarcopenia; nutrition; frailty

Prof. Dr. Norifumi Nakamura

E-Mail Website
Guest Editor

Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
Interests: cancer cachexia; sarcopenia; nutrition; frailty

Special Issue Information

Dear Colleagues,

Head and neck cancer is considered a cancer with a very poor prognosis due to the anatomical characteristics of the head and neck region. Depending on the surgical site and its extent, head and neck cancer is prone to cause functional disabilities such as eating and swallowing disorders. As a result, the risk of developing nutritional disorders, frailty, and sarcopenia increases, ultimately leading to a poor prognosis. Recently, the number of elderly cancer patients aged 65 years or older has been growing every year. Although the number of survivors is increasing due to technological advances in surgical procedures and chemoradiotherapy, it is clear that serious sequelae and functional impairment cause a significant decline in patient QOL. Therefore, it is becoming increasingly important to properly evaluate patients’ conditions and make appropriate treatment choices at each stage of head and neck cancer treatment.

In this Special Issue, we would like to invite submissions on new findings regarding efforts to improve prognosis, especially in head and neck cancer. This Special Issue will provide a basis for new approaches that will lead to a better understanding of the pathogenesis of head and neck cancer and may lead to better treatment choices for patients and improve outcomes.

Dr. Hajime Suzuki
Prof. Dr. Norifumi Nakamura
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

sarcopenia
head and neck cancer
oral cancer
postoperative complications
survival rate
prognosis

Published Papers (3 papers)

Download All Papers

Order results

Result details

Show export options Show export options

Select all

Export citation of selected articles as:

Research

Open AccessArticle

Preoperative CT-Based Skeletal Muscle Mass Depletion and Outcomes after Total Laryngectomy

and

Cancers 2023, 15(14), 3538; https://doi.org/10.3390/cancers15143538 - 08 Jul 2023

Viewed by 495

Abstract

Purpose: To assess the role of preoperative CT-based skeletal muscle mass depletion on postoperative clinical outcomes and survival in patients who underwent total laryngectomy for cancer. Methods: Patients operated on between January 2011 and March 2020 were retrospectively included. Skeletal muscle area and intra- and inter-muscular fat accumulation were measured at the third lumbar vertebral level on preoperative CT scans. Skeletal muscle mass depletion was defined based on pre-established cut-off values. Their association with postoperative morbidity, length of stay (LOS), costs, and survival was assessed. Results: A total of 84 patients were included, of which 37 (44%) had preoperative skeletal muscle mass depletion. The rate of postoperative fistula (23% vs. 35%, p = 0.348), cutaneous cervical dehiscence (17% vs. 11%, p = 0.629), superficial incisional surgical site infections (SSI) (12% vs. 10%, p = 1.000), and unplanned reoperation (38% vs. 37%, p = 1.000) were comparable between the two patient groups. No difference in median LOS was observed (41 vs. 33 days, p = 0.295), nor in treatment costs (119,976 vs. 109,402 CHF, p = 0.585). The median overall survival was comparable between the two groups (3.43 vs. 4.95 years, p = 0.09). Conclusions: Skeletal muscle mass depletion alone had no significant impact on postoperative clinical outcomes or survival. Full article

(This article belongs to the Special Issue Approaches to Improve the Prognosis of Head-and-Neck Cancer)

► Show Figures

Figure 1

Open AccessArticle

Treatment-Interval Changes in Serum Levels of Albumin and Histidine Correlated with Treatment Interruption in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Completing Chemoradiotherapy under Recommended Calorie and Protein Provision

and

Cancers 2022, 14(13), 3112; https://doi.org/10.3390/cancers14133112 - 24 Jun 2022

Cited by 1 | Viewed by 1521

Abstract

We investigated risk factors for treatment interruption (TI) in patients with locally advanced head and neck squamous-cell carcinoma (LAHNSCC) following concurrent chemoradiotherapy (CCRT), under the provision of recommended calorie and protein intake; we also evaluated the associations between clinicopathological variables, calorie and protein supply, nutrition–inflammation biomarkers (NIBs), total body composition change (TBC), and a four-serum-amino-acid metabolite panel (histidine, leucine, ornithine, and phenylalanine) among these patients. Patients with LAHNSCC who completed the entire planned CCRT course and received at least 25 kcal/kg/day and 1 g of protein/kg/day during CCRT were prospectively recruited. Clinicopathological variables, anthropometric data, blood NIBs, CCRT-related factors, TBC data, and metabolite panels before and after treatment were collected; 44 patients with LAHNSCC were enrolled. Nine patients (20.4%) experienced TIs. Patients with TIs experienced greater reductions in hemoglobin, serum levels of albumin, uric acid, histidine, and appendicular skeletal mass, and suffered from more grade 3/4 toxicities than those with no TI. Neither increased daily calorie supply (≥30 kcal/kg/day) nor feeding tube placement was correlated with TI. Multivariate analysis showed that treatment-interval changes in serum albumin and histidine levels, but not treatment toxicity, were independently associated with TI. Thus, changes in serum levels of albumin and histidine over the treatment course could cause TI in patients with LAHNSCC following CCRT. Full article

(This article belongs to the Special Issue Approaches to Improve the Prognosis of Head-and-Neck Cancer)

► Show Figures

Graphical abstract

Open AccessFeature PaperArticle

Prognostic Role of Preoperative Sarcopenia Evaluation of Cervical Muscles with Long-Term Outcomes of Patients with Oral Squamous Cell Carcinoma

and

Cancers 2021, 13(18), 4725; https://doi.org/10.3390/cancers13184725 - 21 Sep 2021

Cited by 8 | Viewed by 1753

Abstract

Accumulating evidence has shown that sarcopenia in patients with oral squamous cell carcinoma (OSCC) is at a risk of poor prognosis. There is no universal consensus on how to assess sarcopenia in patients with OSCC in daily practice. It is important to validate the usefulness of sarcopenia assessment from cervical muscles, which are frequently used in routine clinical practice in patients with OSCC. In this study, we investigated whether preoperative lumbar (L3) skeletal muscle mass and adiposity in OSCC patients were associated with cervical (C3) skeletal muscle mass and adiposity from CT measurements. We also investigated whether skeletal muscle mass and adiposity in the C3 muscles were associated with survival rates in patients with OSCC. We demonstrated that both the quality and quantity of muscle between the C3 and L3 levels were positively correlated with each other. We also demonstrated that the survival rates in patients with low sternocleidomastoid muscle mass index, high processus spinosus muscle-intramuscular adipose tissue content, and the combination of both were significantly lower than those in the controls. These results suggest that the assessment of sarcopenia from multiple neck muscles by preoperative CT measurements may be useful in predicting the prognosis of patients with OSCC. Full article

(This article belongs to the Special Issue Approaches to Improve the Prognosis of Head-and-Neck Cancer)

► Show Figures

Journal Menu

Journal Browser

Special Issue "Approaches to Improve the Prognosis of Head-and-Neck Cancer"

Share This Special Issue

Special Issue Editors

Special Issue Information

Keywords

Published Papers (3 papers)

Research

Further Information

Guidelines

MDPI Initiatives

Follow MDPI